[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [ACTIVE] · [BUSINESS]

2 clusters · 51 sources · 3 days · First seen · Last updated

Brazil pharmaceutical regulation and digital prescriptions

Overview

Brazil’s National Health Surveillance Agency (Anvisa) is managing regulatory oversight regarding pharmaceutical sales and digital prescription systems.

Anvisa has formally notified Mercado Livre to provide information concerning its plans to sell prescription medications online starting in October. The agency is investigating the company’s regulatory compliance, specifically its pharmacy authorization, sanitary licenses, and technical pharmacist identification, noting that current regulations do not automatically authorize marketplaces to intermediate pharmaceutical sales. Anvisa is seeking clarification on protocols for the storage, transport, and verification of medical prescriptions.

This development has impacted market dynamics, causing a decline in shares for major retail pharmacy chains, including Raia Drogasil and Pague Menos, and prompting requests for clarification from the Brazilian Association of Pharmacy and Drugstore Chains (Abrafarma). Mercado Livre has stated it is in dialogue with regulatory bodies and aims to integrate third-party pharmacies into its ecosystem, targeting 20 partners by the end of the year.

In parallel, Anvisa has implemented updates to the National Prescription Control System (SNCR) to facilitate electronic medical prescriptions. The system now enables the electronic issuance and monitoring of blue and yellow prescription notifications, which were previously restricted to paper. Digital oversight has also expanded to include antimicrobials and GLP-1 agonists. While paper prescriptions remain valid, a transition period is underway for white prescriptions; after October 30, any electronic white prescriptions must be integrated into the SNCR.

Entities

Brazil · Anvisa · Ramos Indústria e Comércio de Materiais de Limpeza Ltda. · Mercado Livre · Ascoferj

Claims

What the coverage asserts, and how many sources carry each claim.

Coverage disagrees

Sources make claims that cannot both be true. CLSTR reports the disagreement; it does not decide who is right.

Timeline

  1. [HEALTH] 40 sources
    Anvisa implements new medical prescription rules and cosmetic regulations

    Anvisa has introduced digital medical prescription controls via the SNCR system and implemented new regulations for artisanal cosmetics, while simultaneously banning several counterfeit and unauthorized health/

  2. [BUSINESS] 14 sources
    Mercado Livre notified by Anvisa over prescription drug sales

    Anvisa has notified Mercado Livre to clarify the legality of its plan to sell prescription drugs via its marketplace, amid opposition from pharmacy associations and regulatory uncertainty.

Sources

abradilan.com.br · aredacao.com.br · atarde.com.br · atualidadepolitica.com.br · bandab.com.br · blink102.com.br · bmcnews.com.br · brasil.estadao.com.br · brasilemfolhas.com.br · cenariomt.com.br · chumbogrossomanaus.com.br · clarim.net.br · contabeis.com.br · correiodobrasil.com.br · cotiatododia.com.br · dgabc.com.br · economia.estadao.com.br · elimeira.com.br · exame.com · gazetaderiopreto.com.br · gazetamt.com.br · imagemnews.com.br · infomoney.com.br · inmagazine.ig.com.br · interiordabahia.com.br · jornalenoticias.com.br · lagartocomoeuvejo.com.br · litoralnarede.com.br · mauaagora.com.br · noticiacapital.com.br · odia.ig.com.br · olhardigital.com.br · omatogrosso.com · osul.com.br · paraonline.com.br · parauapebas.pa.gov.br · portaldiarioderondonia.com · portalgilbertosilva.com.br · rapidonoar.com.br · revistadafarmacia.com.br · rpnews.com.br · sao-paulo.estadao.com.br · saobentoemfoco.com.br · sidneysilva.com.br · sitedaserra.com.br · spagora.com.br · tnh1.com.br · tnonline.com.br

This summary has been updated 2 times: see revision history